US Material Events SEC 8-K Filings — June 11, 2026

11-06-2026

PureCycle Technologies announced concurrent public offerings of $250.0M in convertible senior notes due 2032 and $145.0M in common stock, with underwriter over-allotment options of up to $37.5M and $18.75M respectively. The net proceeds will be used to repurchase a portion of its outstanding 7.25% green convertible notes due 2030, for working capital, and general corporate purposes. The offerings are subject to market conditions and there is no assurance of completion.

• · The notes will be general unsecured obligations and accrue interest semiannually in arrears; interest rate and conversion rate to be determined at pricing.
• · PureCycle intends to repurchase a portion of its outstanding 7.25% green convertible notes due 2030 using proceeds from the offerings.
• · The offerings are made under an automatically effective shelf registration statement on Form S-3 (File No. 333-296672) filed June 10, 2026.
• · Morgan Stanley is the sole bookrunner for both offerings.
• · PureCycle holds a global license for patented dissolution recycling technology developed by P&G to transform polypropylene plastic waste (#5 plastic) into PureFive® resin.

11-06-2026

Olenox Industries Inc. (formerly Safe & Green Holdings Corp.) appointed Erik Blum as President effective June 1, 2026, with a one-year employment agreement providing a $200,000 annual base salary, a $50,000 restricted stock grant vesting over 18 months, and an annual performance bonus of up to 20% of base salary. Concurrently, the company dismissed CFO Patricia Kaelin on June 5, 2026, and has begun searching for a replacement. The filing does not disclose any financial results or period-over-period comparisons.

• · Erik Blum has over 30 years of experience in debt, corporate finance, and company management, and previously led FYNN from non-reporting pink sheet status to an audited reporting entity as of November 2023.
• · Blum resigned from the Audit Committee and as Chair of the Audit Committee prior to his appointment as President.
• · Blum is subject to a one-year post-termination non-compete and non-solicit, and confidentiality provisions.
• · Patricia Kaelin was dismissed on June 5, 2026, and the company received her resignation letter the same day.
• · The company will file any response letter from Kaelin with the SEC within two business days of receipt.

11-06-2026

Compass Diversified (CODI) announced that CEO and co-founder Elias Sabo will retire on December 31, 2026, and will be succeeded by Zach Sawtelle, who has been appointed COO and named CEO successor. The company reaffirmed its full-year 2026 outlook with strong subsidiary momentum, while continuing to review its Management Services Agreement to align incentives with shareholders.

• · CEO Elias Sabo will retire as CEO and a director on December 31, 2026.
• · Zach Sawtelle appointed COO effective June 11, 2026, and will succeed Sabo as CEO/Board member upon retirement.
• · Sawtelle joined Compass Group Management in 2009 and led over 20 strategic transactions representing over $3B aggregate value.
• · Sawtelle chairs BOA and held board roles at PrimaLoft, The Honey Pot, 5.11, and Altor Solutions.
• · Company reaffirms previously announced 2026 outlook; expects to complete Management Services Agreement review 'in the coming weeks'.
• · CODI remains focused on reducing leverage, maximizing subsidiary value, and returning capital to shareholders opportunistically.

11-06-2026

AIM ImmunoTech Inc. announced a $2.65 million financing consisting of a registered direct offering and concurrent private placement priced at-market under NYSE American rules. The offering includes 2,554,119 registered shares and 2,554,119 unregistered shares (or pre-funded warrants) plus Class J Warrants to purchase up to 10,216,476 shares at $0.5189 per share, with net proceeds intended for clinical drug supply manufacturing, ongoing and planned Phase 3 clinical trial activities, and working capital. The offering is expected to close on June 10, 2026, subject to customary conditions.

• · The Class J Warrants have a five-year term from the initial exercise date and are exercisable subject to stockholder approval.
• · The registered direct offering is conducted under a shelf registration statement on Form S-3 (File No. 333-286319) declared effective on July 3, 2025.
• · The private placement relies on exemption under Section 4(a)(2) of the Securities Act and Regulation D.
• · Ladenburg Thalmann & Co. Inc. is the exclusive placement agent, with contact details provided for prospectus requests.

11-06-2026

Ciena Corporation announced the pricing of an upsized $2.5 billion aggregate principal amount of 0.00% convertible senior notes due 2031, increased from the previously announced $2.0 billion. The company intends to use approximately $1.14 billion of the net proceeds to repay amounts outstanding under its term loan, $100 million to pay the net cost of convertible note hedge transactions, and $140 million to repurchase approximately 0.3 million shares of common stock at $466.67 per share. The notes carry a conversion premium of approximately 60% over the stock's last reported sale price, and the offering is expected to close on June 11, 2026.

• · The notes will mature on September 15, 2031, unless earlier converted, redeemed or repurchased.
• · Initial conversion rate is 1.3393 shares per $1,000 principal amount of notes.
• · Notes are redeemable at the company's option on or after September 20, 2029, subject to conditions, and also redeemable via a cleanup redemption if less than 10% of the initial principal remains outstanding.
• · The company granted initial purchasers an option to purchase up to an additional $375.0 million in notes within a 13-day period beginning on the first issuance date.
• · The offering is being made only to qualified institutional buyers under Rule 144A.
• · The notes and guarantees have not been registered under the Securities Act.

11-06-2026

PennyMac Financial Services, Inc. (PFSI) announced the appointment of Tiffany To, enterprise AI expert and CEO/Co-Founder of Ontollo, to its Board of Directors, effective June 9, 2026. Ms. To brings deep experience in AI, business transformation, and scaling technology platforms, which aligns with PFSI's tech-first mortgage strategy. The company reported strong operational metrics for the twelve months ended March 31, 2026, with $154 billion in new loan production and $720 billion in loans serviced, employing approximately 5,300 people.

• · Tiffany To holds a Bachelor of Science in Computer Systems Engineering from Stanford University and an MBA from UC Berkeley Haas School of Business.
• · Prior to Ontollo, she was EVP and GM of Enterprise & Platform at Atlassian, leading AI-driven knowledge work systems for 300,000 customers.
• · She served as COO and Board Member at ForAllSecure, building go-to-market strategy for cybersecurity products for the Department of Defense and aerospace/automotive/high-tech clients.
• · PFSI was founded in 2008 and is recognized as a leader in the U.S. residential mortgage industry.

11-06-2026

Wells Fargo Commercial Mortgage Trust 2026-5C9 issued $1.5B in Commercial Mortgage Pass-Through Certificates on May 28, 2026, backed by 29 fixed-rate mortgage loans and subordinate interests in two commercial mortgage loans secured by 138 properties. The filing also details the transfer of servicing for The Towers at Cupertino City Center Mortgage Loan to a new pooling and servicing agreement (BANK5 2026-5YR22) effective June 1, 2026, with substantially similar terms but certain differences in servicing provisions.

• · The Certificates represent the entire beneficial ownership in the Issuing Entity, a common law trust fund formed on May 28, 2026 under New York law.
• · The Towers at Cupertino City Center Whole Loan includes three additional pari passu promissory notes not held by the Issuing Entity.
• · The BANK5 2026-5YR22 Pooling and Servicing Agreement is dated June 1, 2026 and involves KeyBank National Association as special servicer, replacing Rialto Capital Advisors, LLC.
• · The prospectus for the Certificates was filed under Rule 424(b)(2) on May 12, 2026 (SEC File Number 333-282099-13).

11-06-2026

IDT Corp announced the resignation of director Irwin Katsof on June 9, 2026, effective immediately, with no disagreement related to the company's operations. The board appointed William Conkling as a new independent director, effective the same day, to serve as Audit Committee Chairman and Financial Expert, as well as on the Compensation and Corporate Governance Committees. Conkling brings extensive pharmaceutical and commercialization experience, including roles at Protara Therapeutics, Rafael Holdings, and Novartis.

• · William Conkling's term will expire at the 2026 annual meeting of stockholders.
• · Conkling is eligible to participate in the Company’s Non-Employee Director Compensation Program, which includes cash and equity-based awards.
• · Conkling served as CEO of Rafael Holdings from February 2022 to May 2025.
• · Conkling helped lead product commercialization for Immunomedics Inc., which was acquired by Gilead for $21 billion in October 2020.
• · Conkling holds a Bachelor’s Degree from Fordham University and an MBA from NYU Stern School of Business.

11-06-2026

Hallador Energy Company appointed Matthew Bradford White as Chief Legal Officer effective June 8, 2026. Mr. White brings extensive legal and energy industry experience from TransMontaigne Partners, Oracle America, and Morrison & Foerster. The company also disclosed his compensation package, including a $500,000 base salary, performance bonus potential, RSU grants, and change-in-control retention benefits.

• · Mr. White previously served as Executive Vice President, General Counsel and Secretary of TransMontaigne Partners L.L.C. from September 2021 to present.
• · The signing bonus RSUs vest immediately but must be returned if Mr. White voluntarily terminates employment within one year or is terminated for cause.
• · The retention bonus upon change in control includes 2.5 times annualized performance bonus plus prorated bonus for the fiscal year of closing.
• · Mr. White holds a Juris Doctor from the University of Denver Sturm College of Law, an MBA from Daniels College of Business, and a B.S. in Civil Engineering from West Point.
• · There are no family relationships between Mr. White and any director or executive officer, and no material interests in transactions requiring disclosure under Item 404(a).

11-06-2026

Greenland Energy Company (NASDAQ: GLND) announced the appointment of Carol Craig to its Board of Directors, effective June 5, 2026, filling the vacancy created by Daniel M. McCabe's resignation. Ms. Craig, founder and CEO of Sidus Space, brings extensive aerospace and defense experience and will serve on the Audit Committee. The company is preparing for its first modern onshore drilling campaign in Greenland's Jameson Land Basin, currently planned for 2026.

• · Ms. Craig was appointed as a Class I director and will serve on the Audit Committee.
• · She is 59 years old and currently pursuing a Ph.D. in Systems Engineering at Florida Institute of Technology.
• · Sidus Space completed its IPO on Nasdaq in December 2021 and launched three LizzieSat satellites (LS-1 March 2024, LS-2 December 2024, LS-3 March 2025).
• · Prior to Sidus Space, Ms. Craig founded Craig Technologies in 1999, an aerospace and defense engineering firm.
• · She served in the U.S. Navy as a P-3 Orion Naval Flight Officer and was among the first women eligible to fly in combat aircraft.
• · The Board determined Ms. Craig qualifies as an independent director under Nasdaq rules and meets Audit Committee independence requirements under Rule 10A-3.
• · Greenland Energy's licensed area in the Jameson Land Basin is approximately 2 million acres onshore.

11-06-2026

Natural Gas Services Group, Inc. (NGS) held its 2026 annual meeting on June 10, 2026, where shareholders elected three directors, including new board member John E. Jackson, and approved all proposals including executive compensation, ratification of auditors, and the redomestication from Colorado to Texas. The company also entered into an indemnification agreement with Mr. Jackson. Shareholder turnout was high at 84% of outstanding shares, but broker non-votes of 1,215,264 shares were present on all non-routine proposals.

• · The indemnification agreement with John E. Jackson includes expense advancement rights in legal proceedings, subject to repayment if indemnification is later determined not to be owed.
• · Proposal 2 (advisory vote on executive compensation) received 560,762 against votes and 201,904 abstentions, indicating some shareholder dissent.
• · Proposal 3 (ratification of auditor) passed with 10,425,583 for, 3,207 against, and 125,531 abstentions.
• · Proposal 4 (redomestication to Texas) passed with 9,219,513 for, 113,692 against, and 5,852 abstentions.
• · The record date for the meeting was April 16, 2026, with 12,590,213 shares outstanding.

11-06-2026

Melar Acquisition Corp. I (MACIU) entered into a promissory note agreement with its sponsor, Melar Acquisition Sponsor I LLC, for up to $1.5 million to fund working capital needs prior to its proposed initial business combination. The note carries a high 17.5% annual interest rate, with $223,079.12 already advanced. The principal and interest are due upon the earlier of the business combination closing or the company's liquidation, and up to $1.5 million of unpaid amounts may be converted into warrants at the payee's option.

• · The note is unregistered under the Securities Act of 1933 and may not be sold or transferred without registration or a legal opinion.
• · Interest is compounded annually at 17.5%.
• · Drawdowns require a written request and must be funded within five business days; the maximum aggregate drawdown is $1.5 million.
• · Upon an event of default (e.g., failure to pay within one business day of maturity, voluntary/involuntary bankruptcy), the entire unpaid amount becomes immediately due.
• · The payee waives any claim to the trust account established from the IPO proceeds and agrees not to seek recourse against it.
• · Conversion option: at the payee's election, up to $1.5 million of unpaid principal and interest may be converted into warrants to purchase Class A ordinary shares at $1.00 per warrant, identical to the private placement warrants from the IPO.
• · Holders of conversion warrants are entitled to one demand registration and piggyback registration rights under the existing Registration Rights Agreement dated June 17, 2024.
• · The note is governed by Delaware law.

11-06-2026

Veea Inc. raised $8.0 million in a private investment in public equity (PIPE) and a debt conversion, issuing 2.2 million shares of common stock and warrants to purchase an additional 1.5 million shares.

11-06-2026

RMG ML Sports Holdings, a newly organized SPAC, announced the pricing of its $200 million initial public offering of 20,000,000 units at $10.00 per unit. The units are expected to trade on Nasdaq under the ticker 'SHOTU' starting June 10, 2026, with the offering closing on June 11, 2026. The company, led by CEO James Carpenter and CFO Douglas Horlick, intends to target opportunities in the global sports industry and adjacent sectors.

• · The company is a Cayman Islands exempted company.
• · Each unit consists of one Class A ordinary share and one right to receive one-eighth of one Class A ordinary share upon business combination.
• · The ordinary shares and rights are expected to trade under symbols 'SHOT' and 'SHOTR' respectively after separate trading begins.
• · Santander is the sole book-running manager for the offering.
• · The registration statement was declared effective by the SEC on June 9, 2026.
• · The company intends to target opportunities in global sports, entertainment, eSports, gaming, music publishing, and real estate development focused on stadiums and venues.

11-06-2026

Orthofix Medical Inc. held its 2026 Annual Meeting of Shareholders on June 10, 2026, where all director nominees were elected, executive compensation was approved on an advisory basis, Ernst & Young LLP was ratified as independent auditor, and shareholders approved Amendment No. 5 to the Stock Purchase Plan, increasing available shares by 1,250,000. While the advisory vote on executive compensation passed, it received significant opposition with 5,577,200 votes against (18.5% of votes cast), indicating notable shareholder dissent.

• · Director Michael E. Paolucci received the highest number of votes against among all nominees (5,367,249), representing 17.8% of votes cast.
• · Director Wayne Burris also faced notable opposition with 5,162,812 votes against (17.2% of votes cast).
• · The advisory vote on executive compensation had 14,545 abstentions in addition to the 5,577,200 against.
• · Auditor ratification passed overwhelmingly with 33,262,505 votes in favor (96.0% of votes cast).
• · The Stock Purchase Plan amendment was approved with 29,235,005 votes in favor (97.2% of votes cast on the matter).

11-06-2026

Presidio Production Company announced the closing of a $350 million investment-grade ABS refinancing that reduces its weighted-average coupon by 184 bps (from 8.22% to 6.38%) and lowers scheduled amortization, enhancing free cash flow for dividends. The proceeds were used to refinance prior ABS debt, pay down $37 million drawn under its RBL, add $35 million of hedges, and pay expenses; the RBL remains undrawn with a $65 million borrowing base. The press release does not include any negative metrics or flat performance, but the overall sentiment is positive due to lower cost of capital and improved liquidity.

• · The ABS was issued with a master trust and first-of-its-kind oil and gas ABS make-whole provisions.
• · The ABS is redeemable at the Company's option at 102% prior to year 1, 101% prior to year 2, and 100% (par) thereafter.
• · Hedging program details: Oil swaps volume from 274 MBbl (2Q26) to 933 MBbl (Beyond); Natural gas swaps from 6,264 BBtu (2Q26) to 47,417 BBtu (Beyond); Natural gas basis swaps from 5,990 BBtu (2Q26) to 0 (Beyond); NGL swaps from 556 MBbl (2Q26) to 1,316 MBbl (Beyond).
• · Strike prices for oil swaps range from $57.35/Bbl (2Q26) to $108.29/Bbl (2Q27).
• · Strike prices for natural gas swaps range from $6.23/MMBtu (2Q26) to $3.49/MMBtu (Beyond).
• · Previous ABS debt (including accrued interest and make-whole fees) paid off with $263 million of proceeds.
• · RBL borrowing base of $65 million remains undrawn after the $37 million pay down.

11-06-2026

Copley Acquisition Corp (NYSE: COPL) announced a definitive business combination agreement with Ignite Proteomics, a leader in pathway-level protein analytics for precision oncology. The combined entity will be named Ignite Proteomics Holdings, Inc. and will list on the NYSE at a pro forma enterprise value of $150 million. The transaction is expected to close in the second half of 2026, subject to customary conditions and shareholder approvals.

• · Copley is a SPAC that went public via an IPO on December 19, 2023.
• · Ignite's current commercial focus is in breast cancer, with plans to expand into other tumor types.
• · Clear Street LLC acted as financial advisor to Copley; Ladenburg Thalmann & Co. Inc. acted as financial advisor to Ignite.
• · The transaction is subject to adoption by Copley shareholders and Ignite members, as well as other customary closing conditions.

11-06-2026

Tilly's, Inc. held its 2026 annual meeting on June 10, 2026, where stockholders elected seven directors, approved the Fourth Amendment and Restated 2012 Equity and Incentive Award Plan, ratified BDO USA, P.C. as independent auditor, and approved executive compensation on an advisory basis. All proposals passed with strong support, though broker non-votes were significant on most items.

• · All seven director nominees were elected with votes for ranging from 77,128,473 to 77,326,500, and votes withheld from 2,633,871 to 2,831,898.
• · Proposal 2 (Plan approval) received 79,220,610 votes for, 739,201 against, and 560 abstentions.
• · Proposal 3 (auditor ratification) passed with 86,460,798 votes for, 196,042 against, and 8,281 abstentions, with no broker non-votes.
• · Proposal 4 (advisory say-on-pay) received 78,298,527 votes for, 1,263,128 against, and 398,716 abstentions.
• · Broker non-votes were 6,704,750 on Proposals 1, 2, and 4, but zero on Proposal 3.

11-06-2026

Kiora Pharmaceuticals held its 2026 Annual Meeting on June 10, 2026, where shareholders elected three Class II directors (Lisa Walters-Hoffert, Aron Shapiro, and Praveen Tyle, Ph.D.) and approved an amendment to the 2024 Equity Incentive Plan increasing authorized shares by 1,500,000. All proposals received majority support, though broker non-votes on several items were significant, and the equity plan amendment garnered the lowest approval rate among voted shares (approximately 69% for vs. 29% against). The ratification of Haskell & White LLP as independent auditor was overwhelmingly approved with over 99.7% of votes cast in favor.

• · Broker non-votes totaled 1,320,660 on Proposals 1, 2, and 4, representing about 48% of the outstanding shares.
• · Lisa Walters-Hoffert received the most votes for among directors with 1,037,950 (99.26% of votes cast excluding broker non-votes).
• · Praveen Tyle, Ph.D. received the fewest votes for among directors with 1,029,403 (98.45% of votes cast excluding broker non-votes).
• · Proposal 3 (auditor ratification) had no broker non-votes and passed with overwhelming support.

11-06-2026

PetVivo Holdings received $150,000 in gross proceeds from a partial exercise of an investor's purchase option under a Subscription Agreement dated March 13, 2026, bringing total aggregate investment to $1,150,000. The company issued 187,500 Units at $0.80 per Unit, each consisting of one common share and one warrant exercisable at $1.10 per share for three years. While the company has raised a meaningful cumulative amount, the current tranche of $150,000 is relatively modest, and the weighted average price of $0.80 per Unit is well below the warrant exercise price of $1.10, implying limited near-term upside for the warrants.

• · The Offering is conducted under the exemption from registration under Section 4(a)(2) of the Securities Act and Regulation D; the investor is an accredited investor.
• · The Securities issued (shares, warrants, and underlying shares) are restricted securities under Rule 144 and bear a restrictive legend.
• · The investor's remaining purchase option is exercisable through July 15, 2026.
• · The warrants have a three-year expiration from the date of issuance.
• · Common stock trades on OTCQX under symbol PETV; warrants trade on OTCID under symbol PETVW.

11-06-2026

Silvina Moschini resigned as Chief Strategy Officer of Unicoin Inc., effective June 1, 2026, to become Interim CEO of the Unicoin Foundation. The filing highlights a positive regulatory outlook and the company's planned ICO, but no financial metrics or performance data are provided.

• · Resignation effective June 1, 2026.
• · Moschini transitions to Interim CEO of the Unicoin Foundation.
• · Filing references a more constructive regulatory environment and new crypto taxonomy as opportunities.
• · No financial figures, employee counts, or performance metrics are disclosed in this filing.

11-06-2026

Hycroft Mining Holding Corp. entered into an employment agreement with Eric B. Colby as Executive Vice President, Corporate Development and Investor Relations, effective June 8, 2026. Mr. Colby brings extensive mining and capital markets experience, including 15 years at Newmont Corporation and most recently as VP Operations at Magris Performance Materials. The agreement provides a base salary of $450,000, an annual cash incentive bonus target of 80% of base salary (0%-200% range), and includes standard termination and change-in-control provisions.

• · Mr. Colby joined Hycroft in April 2026, prior to the formal employment agreement.
• · Termination without Cause or for Good Reason entitles Mr. Colby to 1.5x base salary paid over 18 months plus 18 months of continued benefits.
• · Termination after a Change in Control (within 90 days before or 1 year after) entitles Mr. Colby to 2.0x base salary plus 2.0x the greater of prior year actual bonus, current year actual bonus, or target bonus, paid in a lump sum on day 60, plus 24 months of continued benefits.
• · The agreement includes standard definitions for Cause, Change in Control, Disability, and Good Reason.
• · Mr. Colby is an at-will employee and may be terminated at any time for any or no reason.

11-06-2026

GE Aerospace announced the appointment of Judson Althoff, CEO of Microsoft’s Commercial Business, to its Board of Directors, effective June 24, 2026. Althoff brings deep experience in AI transformation and commercial strategy, which will support the company's FLIGHT DECK initiative and AI expansion. The filing contains no financial results or negative/declining metrics.

• · Judson Althoff has nearly a decade of experience as chief architect of Microsoft’s commercial strategy.
• · Althoff joined Microsoft in March 2013 as President of Microsoft North America.
• · He previously held senior sales roles at Oracle and EMC.
• · Althoff is a graduate of the Illinois Institute of Technology (IIT).
• · He serves on the board of Ecolab as an independent director and on its Safety, Health & Environment and Finance Committees.
• · GE Aerospace has an installed base of approximately 50,000 commercial and 30,000 military aircraft engines.
• · The company employs approximately 57,000 people globally.

11-06-2026

Allied Energy, Inc. (AGGI) filed an 8-K on June 11, 2026, but the exhibit attached (Ex-99.1) pertains to BILI Social International, Inc.'s Audit Committee Charter, effective June 9, 2026. The filing references Items 5.02, 7.01, 8.01, and 9.01, suggesting potential director/officer changes or other material events, but the provided content only includes the charter. No financial data, officer changes, or other specific events are detailed in the extracted text.

• · The filing includes Items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits).
• · The exhibit is an Audit Committee Charter for BILI Social International, Inc., not directly for Allied Energy, Inc.
• · No specific officer changes, financial results, or material events are described in the provided content.

11-06-2026

Blue Owl Credit Income Corp. issued $1.5B in 6.550% notes due 2031 and entered into a Registration Rights Agreement with initial purchasers including Wells Fargo Securities and others. The company must file an exchange offer registration statement by June 11, 2027, or pay additional interest to noteholders.

• · The notes were issued under an Eleventh Supplemental Indenture dated June 11, 2026, with Truist Bank as trustee.
• · The Registration Rights Agreement requires the company to use commercially reasonable efforts to consummate the exchange offer by June 11, 2027.
• · Failure to meet registration obligations triggers additional interest payments to noteholders.
• · The filing includes forms of notes sold under Rule 144A and Regulation S of the Securities Act.

11-06-2026

On June 5, 2026, Eric Kash resigned as Executive Vice President and Board member of Callan JMB Inc. (CJMB), effective immediately, with no disagreement cited. The company agreed to pay $125,000 in severance (three monthly installments of $41,666.67) plus accrued vacation pay, while Mr. Kash retains 187,500 vested stock options with full 10-year terms. The filing also includes forward-looking statements about Nasdaq compliance, but no financial results or period-over-period comparisons are provided.

• · Resignation effective June 5, 2026, with no disagreement on operations, policies, or practices.
• · Settlement Agreement includes mutual releases, termination of Employment Agreement (dated Oct 1, 2024, as amended Oct 24, 2024), and customary confidentiality/non-disparagement clauses.
• · Forward-looking statements reference intent to submit a plan to regain compliance with Nasdaq Stockholders' Equity Requirement within 45 calendar days.

11-06-2026

At Alphabet Inc.'s 2026 Annual Meeting on June 5, 2026, shareholders elected all 10 director nominees, including Larry Page, Sergey Brin, and Sundar Pichai, and approved an amendment to the 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock. However, the advisory vote on executive compensation (say-on-pay) received significant opposition with 2.33 billion against votes (18.9% of votes cast), and all eight shareholder proposals, including those on climate goals, data privacy, and AI oversight, were not approved. The ratification of Ernst & Young LLP as independent auditor for fiscal year 2026 was approved.

• · Shareholder proposal on climate goals received only 906,706,984 votes for (7.3% of votes cast) and was not approved.
• · Shareholder proposal on AI Board oversight received 461,472,553 votes for (3.7% of votes cast) and was not approved.
• · Shareholder proposal on AI-generated misinformation report received 1,145,766,202 votes for (9.3% of votes cast) and was not approved.
• · Shareholder proposal on AI data usage oversight received 1,510,607,181 votes for (12.2% of votes cast) and was not approved.
• · Shareholder proposal on equal shareholder voting received 3,847,324,128 votes for (31.1% of votes cast) and was not approved.
• · Ratification of Ernst & Young LLP as independent auditor was approved with 12,451,743,976 for, 486,022,124 against, and 13,151,687 abstentions.

11-06-2026

Mohawk Industries announced a CEO succession plan: Paul F. De Cock, currently President and COO, will become CEO and a director effective September 30, 2026, succeeding Jeffrey S. Lorberbaum, who will retire as CEO after 25 years but remain Chairman of the Board. The transition reflects a planned leadership change following a 50-year career for Lorberbaum and over two decades of experience for De Cock, with no financial metrics or performance data provided in the filing.

• · Jeffrey Lorberbaum has served as Chairman since May 2004 and CEO since January 2001.
• · Paul De Cock joined Mohawk through the acquisition of Unilin in 2005.
• · De Cock was appointed President and COO in February 2025 as part of the succession planning process.
• · Mohawk is described as the world's largest flooring manufacturer with leading positions in North America, Europe, South America, and Oceania.
• · The company's brands include American Olean, Daltile, Durkan, Eliane, Elizabeth, Feltex, Godfrey Hirst, Karastan, Marazzi, Mohawk, Mohawk Group, Pergo, Quick-Step, Unilin, and Vitromex.

11-06-2026

Yext, Inc. held its annual meeting on June 10, 2026, where stockholders elected two Class III directors (Daniel Englander and Andrew Sheehan), ratified Ernst & Young LLP as auditor for FY ending January 31, 2027, approved executive compensation on an advisory basis, and approved the amended 2016 Equity Incentive Plan. While all proposals passed, the Plan approval saw significant opposition (14.4 million votes against), and director Andrew Sheehan received a substantial 20.8 million votes against his election.

• · The annual meeting was held on June 10, 2026; record date for voting was April 13, 2026.
• · Daniel Englander received 61,538,851 votes for and 1,389,188 against; Andrew Sheehan received 42,086,549 for and 20,839,792 against.
• · Executive compensation (say-on-pay) was approved with 59,780,340 for, 3,163,149 against, and 97,075 abstentions.
• · The Plan was approved with 48,430,077 for, 14,448,832 against, and 161,655 abstentions.
• · Ernst & Young LLP was ratified as auditor with 72,769,470 for, 738,784 against, and 360,320 abstentions.

11-06-2026

W.R. Berkley Corporation has amended its existing Credit Agreement dated April 1, 2022, to extend the Maturity Date and modify certain provisions, with the amendment executed on June 9, 2026, and reported on Form 8-K on June 11, 2026. The amendment was entered with Bank of America, N.A. as Administrative Agent, and other lenders including M&T Bank, JPMorgan Chase Bank, and Morgan Stanley Bank. The borrower has certified no Default and no Material Adverse Effect since December 31, 2025.

• · The amendment was effective as of June 9, 2026 (the First Amendment Effective Date).
• · Lenders party to the amendment include Bank of America, M&T Bank, JPMorgan Chase Bank, and Morgan Stanley Bank.
• · The amended Credit Agreement was originally entered as of April 1, 2022.
• · The borrower has certified that since December 31, 2025, no event or circumstance that has had or could reasonably be expected to have a Material Adverse Effect has occurred.
• · Legal opinion provided by Norton Rose Fulbright US LLP, counsel to the borrower.
• · The amendment includes standard representations and warranties, including no Default, and compliance with KYC and PATRIOT Act requirements.
• · The exhibit replaced is Exhibit C (Form of Compliance Certificate); other exhibits remain unchanged.

11-06-2026

Organon & Co. held its 2026 Annual Meeting on June 9, 2026, where stockholders approved an amendment and restatement of the 2021 Incentive Stock Plan, increasing the share reserve by 8,000,000 shares. All ten director nominees were elected, and the advisory vote on executive compensation (say-on-pay) passed with approximately 93.9% of votes cast in favor. However, the say-on-pay proposal received 7,311,933 against votes, indicating some shareholder dissent, and the incentive plan amendment also saw 7,608,906 against votes. The ratification of PricewaterhouseCoopers as auditor was overwhelmingly approved with 196,889,135 votes for.

• · The annual meeting had 202,635,304 shares present out of 262,600,862 outstanding, a quorum of ~77%.
• · All ten director nominees were elected with votes for ranging from 143,582,296 (Carrie S. Cox) to 146,867,855 (Ramona Sequeira).
• · The advisory say-on-pay proposal received 142,593,022 for, 7,311,933 against, and 1,968,636 abstentions.
• · The incentive plan amendment received 142,473,542 for, 7,608,906 against, and 1,791,143 abstentions.
• · Auditor ratification received 196,889,135 for, 4,100,954 against, and 1,645,215 abstentions, with no broker non-votes.
• · Broker non-votes totaled 50,761,713 on all proposals except auditor ratification.

11-06-2026

Morgan Stanley Bitcoin Trust filed an 8-K reporting the resignations of directors Ruairi O'Healai (effective June 5, 2026) and Tatiana Segal (effective May 7, 2026) from the Delegated Sponsor. Kaushik Goswami, a Managing Director and former Global Head of Sales & Trading Capital & Funding at Morgan Stanley, was appointed as a director on June 9, 2026, to fill the vacancies. The filing contains no financial results or performance data.

• · Kaushik Goswami holds a degree in Aerospace Engineering from IIT Bombay and a Masters in Financial Engineering from UC Berkeley.
• · Goswami began his career in the Equity Derivatives division at Société Générale in Hong Kong.
• · Goswami has been appointed to the Asset Liability Committee, the ISG Management Committee, and the US Banks Operating Committee.
• · The trust is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

11-06-2026

Universal Health Realty Income Trust (UHT) held its 2026 Annual Meeting on June 10, 2026, where shareholders elected two Class I trustees, approved nonbinding advisory compensation for named executive officers, and ratified KPMG as the independent auditor for FY2026. Additionally, the Compensation Committee granted restricted stock awards to executive officers, including 6,247 shares to CEO Alan B. Miller and 3,631 shares to CFO Charles F. Boyle, with vesting scheduled for the second anniversary. While all proposals passed, a notable 868,560 votes were cast against trustee Robert F. McCadden and 418,954 against executive compensation, indicating some shareholder dissent.

• · The annual meeting was conducted virtually via live audio webcast.
• · All three shareholder proposals passed: election of trustees, advisory compensation, and auditor ratification.
• · CEO Alan B. Miller received 6,247 restricted shares, more than 1.7 times the shares granted to the CFO and SVP Operations (3,631 each).
• · Robert F. McCadden faced relatively high opposition with 868,560 votes against (9.2%) vs. Alan B. Miller's 222,081 (2.4%).
• · There were 2,233,065 non-votes for both trustee proposals and the advisory compensation vote, suggesting a significant portion of shares were not voted.
• · The auditor ratification had zero non-votes, indicating all shares present were voted on that proposal.

11-06-2026

On June 7, 2026, Ingredion Inc. elected Kenneth Escoe as an independent director, effective July 1, 2026. Mr. Escoe, age 51, is the Executive Vice President of Specialty Products at Illinois Tool Works Inc. and will receive standard non-management director compensation consisting of annual cash and equity retainers. No negative or flat performance metrics are present in this filing.

• · Kenneth Escoe has served in roles of increasing responsibility with Illinois Tool Works Inc. since 2014.
• · The Board determined Mr. Escoe qualifies as an independent director under NYSE corporate responsibility standards.
• · Compensation details for non-management directors are described in the company’s definitive proxy statement filed on April 8, 2026.
• · Ingredion will enter into its standard form of director indemnification agreement with Mr. Escoe.

11-06-2026

BeOne Medicines Ltd. held its 2026 Annual General Meeting on June 11, 2026, where shareholders approved all 20 proposals, including the re-election of directors, the appointment of auditors, and the adoption of amended equity incentive plans. Four directors (Michael Goller, Ranjeev Krishana, Corazon D. Sanders, and Qingqing Yi) did not stand for re-election and their terms ended, with no disagreement cited. The meeting saw 73.36% of outstanding shares represented, but notable opposition emerged on several key votes, including the re-election of Dr. Alessandro Riva (with 320 million votes against, or 31.2% of votes cast) and the Connected Person Placing Authorization (which passed with only 42.3% of shares voted in favor, the lowest approval rate).

• · The General Mandate to Issue Shares passed with 719,798,378 votes for and 308,382,843 against (30.0% opposed).
• · The General Mandate to Repurchase Shares passed with 1,027,638,828 votes for and only 562,594 against (0.05% opposed).
• · The advisory vote on Named Executive Officer compensation for FY2025 passed with 975,327,100 for and 52,877,460 against (5.1% opposed).
• · The discharge of the Board of Directors and Executive Management Team from liability passed with 816,696,880 for and 2,683,088 against, but had 177,864,348 abstentions (17.4% of votes cast).
• · The proposal to adjourn the meeting if needed passed with 761,069,153 for and 299,855,418 against (28.3% opposed).

11-06-2026

Bally's Corp subsidiary Bally's Intralot S.A. has agreed to acquire Evoke PLC in an all-share acquisition valued at approximately £243.1 million, with a cash alternative capped at £117.1 million. The acquisition is expected to close between Q4 2026 and Q1 2027, subject to shareholder and regulatory approvals. Bally's Intralot has secured up to €200 million in bridge financing from Deutsche Bank and Jefferies, as well as commitments for a £889 million second lien term facility to refinance Evoke's existing debt, though Bally's Intralot will not provide guarantee or collateral support beyond specific funding obligations.

• · Bally's Corp has agreed to vote its Bally's Intralot shares in favor of resolutions necessary for the acquisition, including share issuance and articles amendment.
• · Evoke has obtained pre-emptive change of control consent waivers from holders of its senior secured notes due 2030 and 2031 and its revolving credit facility.
• · The acquisition is structured as a scheme of arrangement under Part VIII of the Gibraltar Companies Act.
• · Bally's Intralot will not provide guarantee or collateral support for the second lien term facility, except for the mandatory repayment and synergy cost funding obligations.

11-06-2026

Alphatec Holdings, Inc. held its 2026 annual meeting on June 10, 2026, where stockholders approved the 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan, and ratified Deloitte & Touche LLP as auditor. All seven director nominees were elected, with Karen K. McGinnis receiving the highest support (98.4% of votes cast) and Quentin Blackford the lowest (71.1%). The say-on-pay proposal passed with 86.8% support, but the 2026 Equity Incentive Plan received only 70.2% approval, indicating some shareholder dissent.

• · The 2026 Equity Incentive Plan received 66,250,952 votes for, 28,116,490 against, and 273,648 abstentions, with 23,732,518 broker non-votes.
• · The 2026 Employee Stock Purchase Plan received 94,532,324 votes for, 85,516 against, and 23,250 abstentions.
• · Say-on-pay proposal received 81,927,395 votes for, 12,420,476 against, and 293,219 abstentions.
• · Ratification of Deloitte & Touche LLP received 118,309,646 votes for, 48,208 against, and 15,754 abstentions.
• · All director nominees were elected; broker non-votes were 23,732,518 for each nominee.

11-06-2026

Parabilis Medicines, Inc. filed an 8-K on June 11, 2026, announcing the adoption of its Seventh Amended and Restated Certificate of Incorporation, effective upon filing. The amendment reclassifies existing common stock into Voting Common Stock (600M shares authorized) and Non-Voting Common Stock (200M shares authorized), with the Non-Voting Common Stock convertible into Voting Common Stock subject to a 4.99% beneficial ownership limitation (which can be increased up to 19.99% by holders). The filing also authorizes 10M shares of undesignated Preferred Stock. No financial metrics or period-over-period comparisons are provided in this filing.

• · The original Certificate of Incorporation was filed on July 10, 2015, under the name FOG Pharmaceuticals, Inc.
• · The Sixth Amended and Restated Certificate was filed on January 6, 2026, and amended on June 3, 2026.
• · The registered office is at 251 Little Falls Drive, Wilmington, DE 19808, with Corporation Service Company as registered agent.
• · Common stock par value is $0.0001 per share; Preferred Stock par value is also $0.0001 per share.
• · Holders of Non-Voting Common Stock may convert shares into Voting Common Stock only if doing so does not exceed the Beneficial Ownership Limitation.
• · Conversion requires written notice and surrender of certificates (if any) to the Corporation or its transfer agent.

11-06-2026

AECOM entered into a new $1.5 billion revolving credit facility on June 10, 2026, replacing its existing credit agreement. The facility includes an accordion feature allowing for up to $500 million in additional commitments and is priced based on AECOM's consolidated leverage ratio, with initial margins of 1.25% for Term SOFR loans and 0.15% commitment fees. However, the agreement contains extensive negative covenants and events of default that could restrict AECOM's financial flexibility.

• · The credit agreement includes a financial covenant requiring a maximum Consolidated Leverage Ratio of 4.25 to 1.00.
• · The facility is secured by collateral and includes guarantees from certain domestic subsidiaries.
• · The agreement contains provisions for defaulting lenders and mandatory prepayment events.
• · The facility matures on June 10, 2026 (the Closing Date) with a five-year term.
• · The agreement includes representations and warranties related to Sanctions and Anti-Corruption Laws compliance.

11-06-2026

On June 8, 2026, the Compensation and Human Resources Committee of CPI Aerostructures, Inc. approved salary increases for two top executives. CEO and President Dorith Hakim's annual base salary was raised from $405,000 to $425,000 effective May 1, 2026, while CFO and Secretary Robert Mannix's salary was increased from $300,000 to $325,000 effective July 1, 2026. The filing does not provide any financial results or performance metrics, so no period-over-period comparisons are available.

• · The salary increases were approved by the Compensation and Human Resources Committee of the Board of Directors.
• · CEO salary increase effective May 1, 2026; CFO salary increase effective July 1, 2026.
• · The filing is an 8-K dated June 11, 2026, reporting events from June 8, 2026.

11-06-2026

VSee Health, Inc. entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD. on June 2, 2026, allowing the company to sell up to $10 million of common stock over three years at a 3% discount to the lowest daily VWAP. The agreement includes a $25,000 structuring fee and 532,481 commitment shares, but is capped at 9,715,140 shares (19.99% of outstanding stock) unless shareholder approval is obtained. The company cannot draw on the facility until a resale registration statement is effective, and the investor's beneficial ownership is limited to 4.99%.

• · The SEPA has a term ending June 2, 2029, unless terminated earlier.
• · The maximum advance amount per notice is 100% of the 5-day average daily trading volume of VSEE common stock on Nasdaq.
• · The pricing period for each advance is 3 consecutive trading days starting from the advance notice delivery date.
• · The company may terminate the SEPA at any time with 5 trading days' notice, provided no outstanding advances and all fees paid.
• · The investor cannot assign or transfer its rights under the SEPA.
• · The company must file a registration statement for resale of the shares before it can request any advances.

11-06-2026

Reed's, Inc. held its 2026 annual meeting on June 10, 2026, where stockholders approved the 2026 Equity Incentive Plan, ratified the appointment of Weinberg & Company P.A. as independent auditor, and elected all five director nominees. The board also determined, consistent with the stockholder vote, that future advisory votes on executive compensation will be held every three years.

• · The 2026 Equity Incentive Plan was adopted by the Board on March 31, 2026, and became effective upon stockholder approval at the Annual Meeting.
• · All five director nominees were elected with over 7 million votes each and minimal withhold votes (less than 6,000).
• · The ratification of Weinberg & Company P.A. as independent auditor passed overwhelmingly with 8,099,074 votes for and only 10,794 against.
• · The advisory vote on executive compensation passed with 7,068,913 votes for and 5,756 against.
• · Stockholders voted for a three-year frequency for future advisory votes on executive compensation (6,893,600 votes for three years vs. 176,660 for one year).
• · The Board determined that future advisory votes on named executive officer compensation will be held every three years until the next required frequency vote.

11-06-2026

Cardiff Lexington Corporation (CDIX) entered into a common stock purchase agreement and registration rights agreement with an institutional investor on June 5, 2026, securing a committed equity facility of up to $25,000,000, which can be increased to $75,000,000 at the company's sole discretion. The company issued commitment shares valued at $250,000 (or $750,000 if the facility is increased) to the investor. The facility allows CDIX to sell shares at a 3% discount to market price, with a higher 10% discount if the stock price falls below $0.20, and includes a 4.99% beneficial ownership cap and a prohibition on short selling by the investor.

• · The purchase price is the lesser of 97% of the lowest daily VWAP over the prior 5 trading days and 97% of the lowest trading price on the 3rd full trading day after the purchase date.
• · If the stock price is below $0.20 and the investor waives the minimum price requirement, the discount increases to 10% (90% of market price) and the company must reimburse the investor for incremental trading commissions and clearing costs.
• · The company cannot enter into any other equity line of credit, at-the-market offering, or similar continuous offering during the term of the agreement.
• · If the company completes an equity transaction before termination, the investor can require the company to repurchase all outstanding shares (excluding commitment shares) at 100% of the purchase price.
• · The investor is prohibited from engaging in any direct or indirect short selling or hedging of the company's common stock.
• · The company may terminate the agreement at any time without fee, penalty, or cost upon 5 trading days' written notice.

11-06-2026

Dana Incorporated (DAN) entered into a Separation and Distribution Agreement with Eaton Corporation plc on June 10, 2026, under which Eaton will spin off its mobility business (SpinCo) and immediately merge SpinCo with Dana. The transaction is structured as a tax-free spin-off and merger, with Dana shareholders receiving SpinCo shares. The filing does not disclose financial terms or performance metrics.

• · The spin-off is intended to qualify as tax-free under Section 355(a) of the Code for U.S. federal income tax purposes.
• · The merger is intended to qualify as a reorganization under Section 368(a) of the Code.
• · The distribution may be effected as a one-step spin-off or an exchange offer followed by a clean-up spin-off.
• · The agreement includes non-solicitation and non-competition covenants between the parties post-distribution.
• · The filing includes exhibits for Employee Matters, Intellectual Property, Tax Matters, Real Estate, and Transition Services agreements.

11-06-2026

Acadian Asset Management Inc. held its 2026 Annual Meeting on June 11, 2026, where stockholders approved the 2026 Equity Incentive Plan, ratified KPMG LLP as independent auditor, and elected five directors. All proposals passed with strong support, though director Andrew Kim received a notable 15.0% vote against (4,681,683 votes), indicating some shareholder dissent.

• · The 2026 Equity Incentive Plan replaces prior equity plans; no further awards will be granted under the Acadian Asset Management Inc. Equity Incentive Plan or the Non-Employee Directors’ Equity Incentive Plan.
• · Director Andrew Kim received 4,681,683 votes against (15.0% of votes cast), the highest dissent among nominees.
• · Ratification of KPMG LLP passed with 32,652,720 votes for and only 50,882 against (0.2% dissent).
• · Advisory vote on executive compensation passed with 30,451,294 votes for and 752,021 against (2.4% dissent).
• · The 2026 Plan was approved with 30,544,632 votes for and 672,038 against (2.2% dissent).

11-06-2026

At its 2026 Annual Meeting on June 11, 2026, Legence Corp. stockholders approved all five proposals, including the election of Class I directors David Coghlan and Bilal Khan, the advisory say-on-pay vote, a one-year frequency for future advisory votes, the 2026 Employee Stock Purchase Plan (authorizing up to 1,580,053 shares), and the ratification of Deloitte & Touche as independent auditor for fiscal 2026. Notably, Bilal Khan received a significant 21.0 million withhold votes (21.4% of votes cast), indicating notable shareholder dissent, while David Coghlan was elected with only 1.5 million withheld.

• · Bilal Khan received 21,021,430 withhold votes (21.4% of votes cast), a significant level of dissent, while David Coghlan received only 1,481,954 withhold votes.
• · The say-on-pay proposal passed with 95,847,463 FOR votes (97.6% of votes cast), indicating strong shareholder support for NEO compensation.
• · The one-year frequency for future advisory votes on NEO compensation was approved with 97,839,229 FOR votes (97.6% of votes cast).
• · The ESPP was approved with 98,024,042 FOR votes (99.99% of votes cast), with only 4,856 AGAINST.
• · Ratification of Deloitte & Touche as independent auditor for FY2026 passed with 100,320,150 FOR votes (99.98% of votes cast).
• · The company determined to hold an advisory vote on NEO compensation every one year until the next stockholder vote on frequency.

11-06-2026

Marvell Technology announced the appointment of Dan Durn as CFO effective June 15, 2026, succeeding Willem Meintjes, who will remain in an advisory capacity through April 2027. Durn brings over 30 years of semiconductor and enterprise technology financial leadership, having previously served as CFO at Adobe, Applied Materials, NXP, Freescale, and GlobalFoundries. The company also reaffirmed its Q2 fiscal 2027 financial outlook provided on May 27, 2026, indicating no change in expectations.

• · Dan Durn resigned from Marvell's Board of Directors effective June 10, 2026, prior to his CFO appointment.
• · Willem Meintjes will remain available in an advisory capacity through April 2027.
• · Durn holds an MBA in Finance from Columbia Business School and a BS in Control Systems Engineering from the U.S. Naval Academy, and served as a naval officer for six years.
• · The company reaffirmed its Q2 fiscal 2027 financial outlook as provided on May 27, 2026.

11-06-2026

Pacira BioSciences announced that at its 2026 Annual Meeting of Stockholders, all three of the company's director nominees—Christopher Christie, Samit Hirawat, MD, and Thomas Wiggans—were elected to the Board of Directors based on preliminary results. CEO Frank D. Lee expressed gratitude for stockholder trust and reaffirmed the company's commitment to its 5x30 strategy. The filing does not include any financial results or performance metrics, so no positive or negative financial trends are reported.

• · Pacira's commercial-stage non-opioid treatments include EXPAREL, ZILRETTA, and iovera°.
• · The company's most advanced pipeline candidate, PCRX-201, is in Phase 2 clinical development for osteoarthritis of the knee.
• · Goldman Sachs & Co. LLC acted as financial advisor and Perkins Coie LLP as legal counsel to Pacira.
• · Final election results will be tabulated by an independent inspector and reported in a subsequent Form 8-K.

11-06-2026

Weatherford International plc held its 2026 Annual General Meeting and Special Court-Convened Meeting on June 11, 2026. While shareholders approved all annual business items, including the election of directors and the Fifth Amended and Restated 2019 Equity Incentive Plan, the proposed redomestication from Ireland to the United States (Texas) failed to receive the required 75% shareholder support on several key proposals, despite receiving over 60% of votes cast. The company stated that redomestication remains a priority and intends to present an updated proposal to redomesticate to Delaware at a future meeting.

• · The Fifth Amended and Restated 2019 Equity Incentive Plan was approved by shareholders, increasing the share reserve by 565,000 ordinary shares.
• · All six director nominees were elected, with support ranging from approximately 52.96 million votes (Neal P. Goldman) to 64.68 million votes (Girishchandra K. Saligram).
• · The non-binding advisory vote on executive compensation (Say-on-Pay) passed with approximately 64.08 million For votes.
• · Ratification of KPMG as auditor passed with approximately 66.73 million For votes.
• · Authority to issue shares and opt-out of preemption rights under Irish law were approved.
• · The company intends to file a registration statement on Form S-8 to register the additional shares under the equity plan.
• · The redomestication proposals failed to reach the 75% threshold, with support ranging from approximately 61% to 66% of votes cast (excluding broker non-votes).